Compare FDC LTD. with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. IPCA LABS FDC LTD./
IPCA LABS
 
P/E (TTM) x 16.9 32.1 52.6% View Chart
P/BV x 3.3 6.7 48.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 FDC LTD.   IPCA LABS
EQUITY SHARE DATA
    FDC LTD.
Mar-18
IPCA LABS
Mar-19
FDC LTD./
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3191,042 30.6%   
Low Rs164590 27.8%   
Sales per share (Unadj.) Rs61.6298.6 20.6%  
Earnings per share (Unadj.) Rs9.935.0 28.4%  
Cash flow per share (Unadj.) Rs12.049.4 24.2%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs73.2247.1 29.6%  
Shares outstanding (eoy) m174.40126.35 138.0%   
Bonus/Rights/Conversions BBESOS-  
Price / Sales ratio x3.92.7 143.4%   
Avg P/E ratio x24.323.3 104.1%  
P/CF ratio (eoy) x20.216.5 122.3%  
Price / Book Value ratio x3.33.3 99.9%  
Dividend payout %08.6 0.0%   
Avg Mkt Cap Rs m42,118103,108 40.8%   
No. of employees `0005.513.4 41.1%   
Total wages/salary Rs m2,1677,874 27.5%   
Avg. sales/employee Rs Th1,943.72,807.0 69.2%   
Avg. wages/employee Rs Th391.7585.8 66.9%   
Avg. net profit/employee Rs Th313.7329.0 95.4%   
INCOME DATA
Net Sales Rs m10,75137,732 28.5%  
Other income Rs m510577 88.3%   
Total revenues Rs m11,26038,309 29.4%   
Gross profit Rs m2,2676,901 32.9%  
Depreciation Rs m3511,824 19.3%   
Interest Rs m14189 7.4%   
Profit before tax Rs m2,4115,465 44.1%   
Minority Interest Rs m-50-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6711,042 64.4%   
Profit after tax Rs m1,7354,422 39.2%  
Gross profit margin %21.118.3 115.3%  
Effective tax rate %27.819.1 145.9%   
Net profit margin %16.111.7 137.7%  
BALANCE SHEET DATA
Current assets Rs m7,21323,778 30.3%   
Current liabilities Rs m2,10410,975 19.2%   
Net working cap to sales %47.533.9 140.1%  
Current ratio x3.42.2 158.2%  
Inventory Days Days54104 52.5%  
Debtors Days Days2866 42.1%  
Net fixed assets Rs m6,86520,368 33.7%   
Share capital Rs m175253 69.3%   
"Free" reserves Rs m12,58630,971 40.6%   
Net worth Rs m12,76131,224 40.9%   
Long term debt Rs m61,409 0.4%   
Total assets Rs m15,04145,507 33.1%  
Interest coverage x173.230.0 578.2%   
Debt to equity ratio x00 1.0%  
Sales to assets ratio x0.70.8 86.2%   
Return on assets %11.610.1 114.8%  
Return on equity %13.614.2 96.0%  
Return on capital %19.017.3 109.4%  
Exports to sales %12.345.9 26.9%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs m1,32717,308 7.7%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m1,88917,308 10.9%   
Fx outflow Rs m06,266 0.0%   
Net fx Rs m1,88911,042 17.1%   
CASH FLOW
From Operations Rs m1,4984,923 30.4%  
From Investments Rs m201-1,563 -12.9%  
From Financial Activity Rs m-1,694-1,832 92.5%  
Net Cashflow Rs m101,528 0.7%  

Share Holding

Indian Promoters % 68.9 45.9 150.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 11.4 41.2%  
FIIs % 7.5 25.3 29.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.4 109.2%  
Shareholders   23,730 36,892 64.3%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jul 10, 2020 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - UNICHEM LAB COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS